U.S. Stem Cell, Inc. (USRM)
OTCMKTS: USRM · Delayed Price · USD
0.0001
0.00 (0.00%)
Jun 4, 2024, 2:23 PM EDT - Market closed
U.S. Stem Cell Market Cap
U.S. Stem Cell has a market cap or net worth of $64.15 thousand as of July 2, 2024. Its market cap has decreased by -98.47% in one year.
Market Cap
64.15K
Enterprise Value
n/a
1-Year Change
-98.47%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since December 1, 2015, U.S. Stem Cell's market cap has decreased from $1.90M to $64.15K, a decrease of -96.62%. That is a compound annual growth rate of -35.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2023 | 600.00K | -81.25% |
| Dec 30, 2022 | 3.20M | 10.34% |
| Dec 31, 2021 | 2.90M | -40.82% |
| Dec 31, 2020 | 4.90M | 206.25% |
| Dec 31, 2019 | 1.60M | -73.33% |
| Dec 31, 2018 | 6.00M | -39.39% |
| Dec 29, 2017 | 9.90M | 9,800.00% |
| Dec 30, 2016 | 100.00K | -90.91% |
| Dec 31, 2015 | 1.10M | -42.11% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 860.48B |
| Novo Nordisk | 629.27B |
| UnitedHealth Group | 468.72B |
| Johnson & Johnson | 351.76B |
| Merck & Co. | 313.56B |
| AbbVie | 302.88B |
| AstraZeneca | 241.81B |
| Thermo Fisher | 211.09B |